385 related articles for article (PubMed ID: 25709093)
1. RNA degradation in antiviral immunity and autoimmunity.
Rigby RE; Rehwinkel J
Trends Immunol; 2015 Mar; 36(3):179-88. PubMed ID: 25709093
[TBL] [Abstract][Full Text] [Related]
2. Mouse models for Aicardi-Goutières syndrome provide clues to the molecular pathogenesis of systemic autoimmunity.
Behrendt R; Roers A
Clin Exp Immunol; 2014 Jan; 175(1):9-16. PubMed ID: 23713592
[TBL] [Abstract][Full Text] [Related]
3. Aicardi-Goutières syndrome: a model disease for systemic autoimmunity.
Lee-Kirsch MA; Wolf C; Günther C
Clin Exp Immunol; 2014 Jan; 175(1):17-24. PubMed ID: 23786362
[TBL] [Abstract][Full Text] [Related]
4. Adenosine deaminase acting on RNA 1 limits RIG-I RNA detection and suppresses IFN production responding to viral and endogenous RNAs.
Yang S; Deng P; Zhu Z; Zhu J; Wang G; Zhang L; Chen AF; Wang T; Sarkar SN; Billiar TR; Wang Q
J Immunol; 2014 Oct; 193(7):3436-45. PubMed ID: 25172485
[TBL] [Abstract][Full Text] [Related]
5. Links between recognition and degradation of cytoplasmic viral RNA in innate immune response.
Oshiumi H; Mifsud EJ; Daito T
Rev Med Virol; 2016 Mar; 26(2):90-101. PubMed ID: 26643446
[TBL] [Abstract][Full Text] [Related]
6. Intracellular Nucleic Acid Detection in Autoimmunity.
Crowl JT; Gray EE; Pestal K; Volkman HE; Stetson DB
Annu Rev Immunol; 2017 Apr; 35():313-336. PubMed ID: 28142323
[TBL] [Abstract][Full Text] [Related]
7. Therapies in Aicardi-Goutières syndrome.
Crow YJ; Vanderver A; Orcesi S; Kuijpers TW; Rice GI
Clin Exp Immunol; 2014 Jan; 175(1):1-8. PubMed ID: 23607857
[TBL] [Abstract][Full Text] [Related]
8. Type I interferonopathies: a novel set of inborn errors of immunity.
Crow YJ
Ann N Y Acad Sci; 2011 Nov; 1238():91-8. PubMed ID: 22129056
[TBL] [Abstract][Full Text] [Related]
9. The Type I Interferonopathies.
Lee-Kirsch MA
Annu Rev Med; 2017 Jan; 68():297-315. PubMed ID: 27813875
[TBL] [Abstract][Full Text] [Related]
10. Sources of Pathogenic Nucleic Acids in Systemic Lupus Erythematosus.
Mustelin T; Lood C; Giltiay NV
Front Immunol; 2019; 10():1028. PubMed ID: 31139185
[TBL] [Abstract][Full Text] [Related]
11. Aicardi-Goutières syndrome-associated mutation at ADAR1 gene locus activates innate immune response in mouse brain.
Guo X; Wiley CA; Steinman RA; Sheng Y; Ji B; Wang J; Zhang L; Wang T; Zenatai M; Billiar TR; Wang Q
J Neuroinflammation; 2021 Jul; 18(1):169. PubMed ID: 34332594
[TBL] [Abstract][Full Text] [Related]
12. Breaching Self-Tolerance to Alu Duplex RNA Underlies MDA5-Mediated Inflammation.
Ahmad S; Mu X; Yang F; Greenwald E; Park JW; Jacob E; Zhang CZ; Hur S
Cell; 2018 Feb; 172(4):797-810.e13. PubMed ID: 29395326
[TBL] [Abstract][Full Text] [Related]
13. Autoinflammatory phenotypes in Aicardi-Goutières syndrome with interferon upregulation and serological autoimmune features.
Sugawara Y; Imai K; Kashimada A; Moriyama K; Baba S; Nishikomori R; Motegi M; Takeuchi Y; Morio T
J Allergy Clin Immunol; 2018 Mar; 141(3):1135-1138. PubMed ID: 29132962
[No Abstract] [Full Text] [Related]
14. Aicardi-Goutières syndrome and systemic lupus erythematosus (SLE) in a 12-year-old boy with SAMHD1 mutations.
Ramantani G; Häusler M; Niggemann P; Wessling B; Guttmann H; Mull M; Tenbrock K; Lee-Kirsch MA
J Child Neurol; 2011 Nov; 26(11):1425-8. PubMed ID: 21670392
[TBL] [Abstract][Full Text] [Related]
15. Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome.
Meuwissen ME; Schot R; Buta S; Oudesluijs G; Tinschert S; Speer SD; Li Z; van Unen L; Heijsman D; Goldmann T; Lequin MH; Kros JM; Stam W; Hermann M; Willemsen R; Brouwer RW; Van IJcken WF; Martin-Fernandez M; de Coo I; Dudink J; de Vries FA; Bertoli Avella A; Prinz M; Crow YJ; Verheijen FW; Pellegrini S; Bogunovic D; Mancini GM
J Exp Med; 2016 Jun; 213(7):1163-74. PubMed ID: 27325888
[TBL] [Abstract][Full Text] [Related]
16. Aicardi-Goutières syndrome-like encephalitis in mutant mice with constitutively active MDA5.
Onizawa H; Kato H; Kimura H; Kudo T; Soda N; Shimizu S; Funabiki M; Yagi Y; Nakamoto Y; Priller J; Nishikomori R; Heike T; Yan N; Tsujimura T; Mimori T; Fujita T
Int Immunol; 2021 Mar; 33(4):225-240. PubMed ID: 33165593
[TBL] [Abstract][Full Text] [Related]
17. Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling.
Rice GI; Del Toro Duany Y; Jenkinson EM; Forte GM; Anderson BH; Ariaudo G; Bader-Meunier B; Baildam EM; Battini R; Beresford MW; Casarano M; Chouchane M; Cimaz R; Collins AE; Cordeiro NJ; Dale RC; Davidson JE; De Waele L; Desguerre I; Faivre L; Fazzi E; Isidor B; Lagae L; Latchman AR; Lebon P; Li C; Livingston JH; Lourenço CM; Mancardi MM; Masurel-Paulet A; McInnes IB; Menezes MP; Mignot C; O'Sullivan J; Orcesi S; Picco PP; Riva E; Robinson RA; Rodriguez D; Salvatici E; Scott C; Szybowska M; Tolmie JL; Vanderver A; Vanhulle C; Vieira JP; Webb K; Whitney RN; Williams SG; Wolfe LA; Zuberi SM; Hur S; Crow YJ
Nat Genet; 2014 May; 46(5):503-509. PubMed ID: 24686847
[TBL] [Abstract][Full Text] [Related]
18. SAMHD1 prevents autoimmunity by maintaining genome stability.
Kretschmer S; Wolf C; König N; Staroske W; Guck J; Häusler M; Luksch H; Nguyen LA; Kim B; Alexopoulou D; Dahl A; Rapp A; Cardoso MC; Shevchenko A; Lee-Kirsch MA
Ann Rheum Dis; 2015 Mar; 74(3):e17. PubMed ID: 24445253
[TBL] [Abstract][Full Text] [Related]
19. cGAS activation causes lupus-like autoimmune disorders in a TREX1 mutant mouse model.
Xiao N; Wei J; Xu S; Du H; Huang M; Zhang S; Ye W; Sun L; Chen Q
J Autoimmun; 2019 Jun; 100():84-94. PubMed ID: 30872080
[TBL] [Abstract][Full Text] [Related]
20. Unusual cutaneous features associated with a heterozygous gain-of-function mutation in IFIH1: overlap between Aicardi-Goutières and Singleton-Merten syndromes.
Bursztejn AC; Briggs TA; del Toro Duany Y; Anderson BH; O'Sullivan J; Williams SG; Bodemer C; Fraitag S; Gebhard F; Leheup B; Lemelle I; Oojageer A; Raffo E; Schmitt E; Rice GI; Hur S; Crow YJ
Br J Dermatol; 2015 Dec; 173(6):1505-13. PubMed ID: 26284909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
